ATE169916T1 - Neue makrocyclische stickstoff-liganden, verfahren zu ihrer herstellung, metallkomplexe, diagnostische und therapeutische zusammensetzungen - Google Patents

Neue makrocyclische stickstoff-liganden, verfahren zu ihrer herstellung, metallkomplexe, diagnostische und therapeutische zusammensetzungen

Info

Publication number
ATE169916T1
ATE169916T1 AT92400174T AT92400174T ATE169916T1 AT E169916 T1 ATE169916 T1 AT E169916T1 AT 92400174 T AT92400174 T AT 92400174T AT 92400174 T AT92400174 T AT 92400174T AT E169916 T1 ATE169916 T1 AT E169916T1
Authority
AT
Austria
Prior art keywords
diagnostic
preparation
image
metal complexes
therapeutic compositions
Prior art date
Application number
AT92400174T
Other languages
English (en)
Inventor
Olivier Rousseaux
Michel Schaefer
Anne Bouillot
Dominique Meyer
Original Assignee
Guerbet Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guerbet Sa filed Critical Guerbet Sa
Application granted granted Critical
Publication of ATE169916T1 publication Critical patent/ATE169916T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0474Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0482Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00Preparations for testing in vivo
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/24Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT92400174T 1991-01-24 1992-01-22 Neue makrocyclische stickstoff-liganden, verfahren zu ihrer herstellung, metallkomplexe, diagnostische und therapeutische zusammensetzungen ATE169916T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9100811A FR2672051B1 (fr) 1991-01-24 1991-01-24 Nouveaux ligands macrocycliques azotes, procede de preparation, complexes polymetalliques, composition de diagnostic et therapeutique.

Publications (1)

Publication Number Publication Date
ATE169916T1 true ATE169916T1 (de) 1998-09-15

Family

ID=9409017

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92400174T ATE169916T1 (de) 1991-01-24 1992-01-22 Neue makrocyclische stickstoff-liganden, verfahren zu ihrer herstellung, metallkomplexe, diagnostische und therapeutische zusammensetzungen

Country Status (18)

Country Link
US (1) US5374416A (de)
EP (1) EP0499501B1 (de)
JP (1) JPH0735381B2 (de)
KR (1) KR960014355B1 (de)
AT (1) ATE169916T1 (de)
AU (1) AU650325B2 (de)
CA (1) CA2078983A1 (de)
CZ (1) CZ281225B6 (de)
DE (1) DE69226669T2 (de)
FR (1) FR2672051B1 (de)
HU (1) HUT70023A (de)
IE (1) IE920204A1 (de)
IL (1) IL100717A (de)
MX (1) MX9200319A (de)
NO (1) NO923673L (de)
NZ (1) NZ241356A (de)
WO (1) WO1992012978A1 (de)
ZA (1) ZA92470B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03504510A (ja) * 1989-02-10 1991-10-03 セルテック リミテッド アザマクロサイクルおよびその製法
US5645818A (en) * 1989-03-24 1997-07-08 Guerbet S.A. Diagnostic compositions comprising a complex formed by a nitrogenous macrocyclic ligand with metal ions
GB9126677D0 (en) * 1991-12-16 1992-02-12 Johnson Matthey Plc Improvements in chemical compounds
US5462725A (en) * 1993-05-06 1995-10-31 The Dow Chemical Company 2-pyridylmethylenepolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents
DE4318369C1 (de) * 1993-05-28 1995-02-09 Schering Ag Verwendung von makrocyclischen Metallkomplexen als Temperatursonden
US6693190B1 (en) 1994-05-11 2004-02-17 Bracco International B.V. Enhanced relaxivity monomeric and multimeric compounds
WO1998039406A1 (en) * 1997-03-07 1998-09-11 The Procter & Gamble Company Bleach compositions
US20030017941A1 (en) * 1997-03-07 2003-01-23 The Procter & Gamble Company Catalysts and methods for catalytic oxidation
US20080125344A1 (en) * 2006-11-28 2008-05-29 Daryle Hadley Busch Bleach compositions
ZA981883B (en) * 1997-03-07 1998-09-01 Univ Kansas Catalysts and methods for catalytic oxidation
US6565828B2 (en) 2000-04-07 2003-05-20 Bristol-Myers Squibb Company Macrocyclic chelants for metallopharmaceuticals
ES2398399T3 (es) * 2000-09-29 2013-03-15 Genzyme Corporation Procedimiento para la preparación de poliaminas cíclicas que contienen n nitrógenos en el anillo con n-1 protegidos y sus productos
DE10117242C1 (de) * 2001-04-06 2002-05-16 Schering Ag Unsymmetrische dimere Metallkomplexe, Liganden für diese Metallkomplexe, Verfahren zu deren Herstellung, Arzneimittel bzw. Diagnosemittel, die die Metallkomplexe enthalten, insbesondere Kontrastmittel
CN102302493B (zh) * 2001-07-31 2015-08-12 健赞股份有限公司 活化祖细胞/干细胞的方法
US20050192195A1 (en) * 2002-08-27 2005-09-01 Busch Daryle H. Catalysts and methods for catalytic oxidation
US20040048763A1 (en) * 2002-08-27 2004-03-11 The Procter & Gamble Co. Bleach compositions
EP1637524A1 (de) * 2004-09-20 2006-03-22 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. 10-substituierte 1-, 4, 7,-tris (carboxymethyl)-1,4,7,10-tetraazacyclo-dodecanederivate zur Verwendung als Kontrastmittel
TWI429404B (zh) * 2008-03-03 2014-03-11 Senomyx Inc 異山梨醇衍生物及彼等作為風味改良劑、促味劑及促味增強劑之用途
JP5735791B2 (ja) * 2010-12-07 2015-06-17 住友化学株式会社 金属錯体を含む素子
FR2968999B1 (fr) 2010-12-20 2013-01-04 Guerbet Sa Nanoemulsion de chelate pour irm
WO2017165841A1 (en) 2016-03-25 2017-09-28 Nanoprobes, Inc. Iodine-based particles
CN108779082B (zh) * 2016-04-13 2022-08-02 伯拉考成像股份公司 造影剂

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53144592A (en) * 1977-05-19 1978-12-15 Tabuse Iwao 122alkyll1*4*7*100tetrazacyclotridecane
EP0299795B1 (de) * 1987-07-16 1992-03-18 Nycomed As Aminopolycarbonsäure und ihre Derivate
DE3728525A1 (de) * 1987-08-24 1989-03-16 Schering Ag Mehrkernige substituierte komplexbildner, komplexe und komplexsalze, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel
JP2930709B2 (ja) * 1988-12-22 1999-08-03 ザ ダウ ケミカル カンパニー モノ―n―アルキル化ポリアザ大員環の製造方法

Also Published As

Publication number Publication date
KR960014355B1 (ko) 1996-10-15
CZ290992A3 (en) 1993-02-17
EP0499501A2 (de) 1992-08-19
HU9203029D0 (en) 1992-12-28
AU650325B2 (en) 1994-06-16
DE69226669T2 (de) 1999-04-15
FR2672051A1 (fr) 1992-07-31
MX9200319A (es) 1992-07-01
US5374416A (en) 1994-12-20
EP0499501A3 (de) 1992-08-26
JPH05504361A (ja) 1993-07-08
HUT70023A (en) 1995-09-28
FR2672051B1 (fr) 1993-05-21
IE920204A1 (en) 1992-07-29
NO923673D0 (no) 1992-09-22
EP0499501B1 (de) 1998-08-19
DE69226669D1 (de) 1998-09-24
IL100717A0 (en) 1992-09-06
AU1256292A (en) 1992-08-27
IL100717A (en) 1996-06-18
ZA92470B (en) 1993-07-23
CZ281225B6 (cs) 1996-07-17
NO923673L (no) 1992-11-24
NZ241356A (en) 1995-02-24
WO1992012978A1 (fr) 1992-08-06
CA2078983A1 (fr) 1992-07-25
JPH0735381B2 (ja) 1995-04-19

Similar Documents

Publication Publication Date Title
ATE169916T1 (de) Neue makrocyclische stickstoff-liganden, verfahren zu ihrer herstellung, metallkomplexe, diagnostische und therapeutische zusammensetzungen
DE69019584T2 (de) Makrocyclische Stickstoffliganden Verfahren zu ihrer Herstellung, ihre Metallkomplexe, sie enthaltende Diagnostische und therapeutische Mittel.
EP0448191B1 (de) 1,4,7,10-Tetraazacyclododecan-butyltriole, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
ATE135237T1 (de) Molekularsieb enthaltende pharmazeutische ionen für diagnose
IL86059A (en) Nitrogen-containing cyclic ligands, metallic complexes thereof, diagnostic compositions containing these complexes and the preparation of the ligands
IL109852A0 (en) Iodinated paramagnetic chelates
KR930007462A (ko) 진단용 조영제
EP0463644A3 (en) Use of chelate complexes
KR930019648A (ko) 테트라아자시클로도덴칸 유도체 및 그의 용도
EP0483704A1 (de) Verfahren zur Herstellung einer radiopharmazeutischer Zubereitung
EP1355913A4 (de) Komplexverbindungen aus paramagnetischem metall und phthalocyanin und kontrastmittel, bei dem diese verbindungen verwendet werden
ATE151406T1 (de) Derivatisierte dtpa-komplexe, diese verbindungen enthaltende pharmazeutische mittel, ihre verwendung als nmr- und röntgenkontrastmittel und verfahren zu deren herstellung
WO1995014678A1 (de) 1,4,7,10-tetraazacyclododecan-derivate, deren verwendung, diese enthaltende pharmazeutische mittel und verfahren zu deren herstellung
DE19641197C2 (de) Ionenpaare und ihre Verwendung als Kontrastmittel
NO912755L (no) Chelateringsmiddel-derivater.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties